Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-28 · accession 0000874015-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-02 | 2023-12-28 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $47.34 | +11.5K | 48.0K | +31% | +$544.4K |
| D | 2024-01-02 | 2023-12-28 | IONS | Birchler Brian | EVP, Corp, Development Ops | F - Tax | $50.50 | -11.0K | 37.0K | -23% | -$557.0K |
| D | 2024-01-02 | 2023-12-28 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $0.00 | -11.5K | 15.5K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-28 | M | A | 11,500 | $47.34 | 48,028 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-28 | F | D | 11,029 | $50.50 | 36,999 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-12-28 | M | D | 11,500 | $0.00 | 15,482 | D | $47.34 · 2020-01-03 to 2024-01-02 | 11,500 Common Stock |